2008 U.S. Food and Drug Administration Critical Path Workshop. Clinical trials for local treatment of breast cancer by thermal ablation

 


Quick Links

Critical Path Initiative

Invited Discussant Bios

Thomas Julian, M.D.

Thomas Julian is an accomplished breast cancer surgeon, researcher, and educator, currently serving as Associate Director of the Allegheny Breast Center, Staff Surgeon in the Division of Surgical Oncology at Allegheny General Hospital, and Associate Professor, Human Oncology at Drexel University College of Medicine. He has been a principal investigator for numerous breast cancer pre- and post-launch clinical trials studying topics such as primary systemic combination drug therapy in postmenopausal hormone receptor-positive breast cancer patients, the GeneSearch™ breast lymph node assay for intra-operative molecular testing, digital mammography imaging, and MRI evaluation of the contralateral breast in recently diagnosed female breast cancer patients, among others. Together with colleagues Yoed Rabin and Norman Wolmark, Dr. Julian was awarded two U.S. patents for developing new methods and equipment for use in cryosurgery. He is the Protocol Officer for breast cancer trials conducted by the National Surgical Adjuvant Breast and Bowel Project (NASBP), for which he serves as Senior Associate Director of Medical Oversight. Dr. Julian's research and expertise have been widely published, appearing in more than 120 articles, reviews, book chapters, audiovisual displays, abstracts, and scientific exhibits. He completed his undergraduate degree in chemistry at University of Pittsburgh, and obtained his medical degree from the University of Pittsburgh School of Medicine.

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 
Sponsored by the FDA: September 15, 2008 | FDA White Oak Campus | Building 21 | 10903 New Hampshire Avenue | Silver Spring, MD 20993
Register Online Now!  Registration Quick Link